Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

DelMar Receives IND Allowance from FDA to Initiate Clinical Trials of VAL-083

americanpharmaceuticacreviewSeptember 19, 2017

Tag: DelMar , FDA , Clinical Trials of VAL-083

PharmaSources Customer Service